Clinical and Prognostic Significance of Glutathione Peroxidase 2 in Lung Adenocarcinoma
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.High glutathione peroxidase 2 (GPX2) expression in lung adenocarcinoma indicates a more aggressive tumor. This antioxidant enzyme is linked to advanced stage and poor survival, serving as a key prognostic factor.
Area Of Science
- Oncology
- Molecular Biology
- Biochemistry
Background
- Glutathione peroxidase 2 (GPX2) is an antioxidant enzyme implicated in cancer progression.
- The role of GPX2 in lung adenocarcinoma prognosis remains unclear.
Purpose Of The Study
- To investigate the clinical significance and prognostic value of GPX2 in lung adenocarcinoma.
Main Methods
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) for GPX2 mRNA.
- Immunohistochemistry (IHC) to assess GPX2 protein expression in 351 lung adenocarcinoma specimens.
- Correlation analysis with clinicopathological characteristics and survival outcomes.
Main Results
- GPX2 mRNA levels were elevated in tumor cells compared to normal tissues.
- High GPX2 expression correlated with male sex, smoking, advanced stage, and invasion (pleural, lymphatic, vascular).
- Elevated GPX2 was associated with shorter recurrence-free survival (RFS) and overall survival, and identified as an independent prognostic factor for RFS.
Conclusions
- GPX2 expression is significantly associated with pathological malignancy in lung adenocarcinoma.
- High GPX2 expression may reflect increased tumor aggressiveness.
- GPX2 serves as a significant prognostic marker for poor outcomes in resected lung adenocarcinoma.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.